How many insider declarations does 博雅生物 have?

博雅生物 has filed 1 insider declaration with AMF.

Who is the top reporting insider at 博雅生物?

The top reporting insider at 博雅生物 is 梁小明, based on the count of public filings.

What is the net insider buy vs sell volume on 博雅生物?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

博

博雅生物: management transactions · France · AMF

SZSE:300294FR·AMFMcap 11.4Bn€

AMF ↗

Browse the full management transaction log of 博雅生物, a publicly traded company based in France. Shares trade on FR FR, under the supervision of AMF. Market capitalisation: €11.4bn. The latest transaction was filed on 16 June 2021 — Purchase. Among the most active insiders: 梁小明. The full history is accessible without an account.

1

Insider Decl.

0

Thresholds

·

1 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

16.03 €

Income statement

Revenue2.06 Bn€

Gross profit1.03 Bn€50% margin

Net income112.7 M€5.5% margin

Balance sheet & cash

Market cap11.40 Bn€

Total debt65.6 M€

Free Cash Flow−474.1 M€

Last declaration on 16 June 2021

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations